PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24568186-3	2014	In the present work, we investigated the effects of HO-1 on the expression of p53 induced by 15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ2) in human breast cancer (MCF-7) cells.	9-deoxy-delta-9-prostaglandin D2	115-131	tumor protein p53	Homo sapiens	78-81	
14704122-3	2004	RESULTS: The 15d-PGJ2 induced apoptosis in ECV304 endothelial cells in a dose-dependent manner (the percentage of apoptosis was enhanced from 10.0 %+/-1.3 % to 32.8 %+/-1.6 %), which was accompanied by inhibition of NF-?B and AP-1 DNA binding activity, down-regulation of c-myc, upregulation of Gadd45 and p53, and activation of p38 kinase.	9-deoxy-delta-9-prostaglandin D2	17-21	tumor protein p53	Homo sapiens	306-309	
9792828-0	1998	p53-Independent activation of the gadd45 promoter by Delta12-prostaglandin J2.	9-deoxy-delta-9-prostaglandin D2	61-77	tumor protein p53	Homo sapiens	0-3	
14636064-3	2003	In the study presented here, we investigated the molecular mechanisms involved in the 15d-PGJ(2)-induced accumulation of p53.	9-deoxy-delta-9-prostaglandin D2	90-96	tumor protein p53	Homo sapiens	121-124	
26801686-3	2016	Therefore, the present study aimed to elucidate the impact of 15-deoxy-Delta(12,14)-PGJ2 (15d-PGJ2, a stable PGD2 degradation product) on cell death/cell survival pathways in p53-deficient MG-63 OS cells.	9-deoxy-delta-9-prostaglandin D2	83-88	tumor protein p53	Homo sapiens	175-178